Specific inhibition of dihydrofolate reductase and compounds therefor
CA 2095518 A1 · Owner: Chiron Corporation · Inventors: Marlow, Charles K.; Kompis, Ivan; Blaney, Jeffrey M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds derived from pyrimidines having improved activity against fungi such as Pneumocystis carinii and improved, selectivity for P. carinii dihydrofolate reductase over human dihydrofolate reductase, are disclosed. P. carinii pneumonia is advantageously treated with the disclosed compounds.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 14, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 14, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 14, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.